Description
Buy B7-33 Online
B7-33 is a synthetic peptide analogue derived from the B-chain of relaxin-2. It has attracted research interest in cardiovascular, vascular, fibrosis, and tissue-remodeling pathways.
Product Information
B7-33 is designed as a functionally selective agonist of relaxin family peptide receptor 1 (RXFP1). Research has primarily been conducted in cellular and animal models, including studies of cardiac remodeling and vascular function.
How Does It Work?
B7-33 activates RXFP1-related signaling and has been investigated for effects involving ERK1/2 and vasoprotective pathways associated with relaxin biology. Preclinical studies have reported effects on cardiac remodeling and vascular function.
Benefits
Cardiovascular Research
Animal studies have investigated B7-33 in ischemia-reperfusion injury and cardiac remodeling, including effects on infarct size and cardiac function.
Vascular Research
B7-33 has demonstrated vasoprotective activity in experimental models, providing a basis for research into vascular signaling.
Fibrosis Research
Because relaxin signaling is involved in tissue remodeling and fibrosis pathways, B7-33 has been investigated as a potential research tool for these mechanisms.
RXFP1 Signaling
B7-33 offers a more selective model for studying RXFP1-mediated signaling compared with the broader biological activity of native relaxin.
Side Effects
No established human safety profile exists. Potential risks cannot be reliably predicted from animal studies alone, particularly for systemic cardiovascular or hormonal effects.
Dosage
There is no established human dosage for B7-33. Published research has used experimental doses in animal models, which should not be converted into human dosing.
Where to Buy B7-33
Purerawz does not directly sell B7-33. Readers should verify peptide identity, purity, sequence confirmation, and analytical documentation from any independent third-party provider.
References
Marshall SA et al. B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin). European Journal of Pharmacology. 2017;807:190-197.
Devarakonda T et al. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice. JAHA. 2020.
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party suppliers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information on these pages is provided for educational and informational purposes only. Dosage figures may reflect published research protocols or reported community use and should not be interpreted as personalized medical instructions. Research findings, particularly animal and early-stage studies, do not necessarily translate into established human benefits or safety.
Reviews
There are no reviews yet.